ARIEL
Selecting patients with RAS wild-type advanced colorectal cancer
and right primary tumour location for effective anti-EGFR treatment
and right primary tumour location for effective anti-EGFR treatment
About ARIEL
ARIEL is a clinical trial looking at whether extra tests on cancer samples can identify more patients with bowel/colon cancer who should be treated with drugs called anti-EGFR agents.
This website is intended to help:
- Patients and the public who want to know more about ARIEL – use the For Patients link above
- Healthcare professionals – use the For Researchers link above
40
UK hospitals
participants
recruited
